AI and PET-MRI scans aim to personalize cancer radiation therapy
NCT ID NCT06256705
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is looking at people with a rare type of digestive system cancer called GEP-NET who are receiving a targeted radiation therapy (PRRT). Researchers will use special PET-MRI scans and artificial intelligence to find patterns that predict how well the treatment works. The goal is to better select patients who will benefit most from PRRT. About 80 participants will be followed for 18 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 68Ga-DOTATOC PET-MRI imaging
- What this could lead to
- If successful, this could lead to better ways to predict which patients will benefit most from targeted radiation therapy for GEP-NET tumors.
- What could go wrong
- This is an observational imaging study, not a treatment trial. It will not directly test a new therapy, and results may not change current practice for years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hépato-gastro-entérologie, cancérologie digestive et assistance nutritionnelle - CHU Nantes
ACTIVE_NOT_RECRUITINGNantes, 44000, France
-
Médecine nucléaire - CHU Nantes
RECRUITINGNantes, 44000, France
-
Médecine nucléaire et Biophysique - Beaujon
RECRUITINGClichy, 92110, France
-
Pancréatologie et Oncologie Digestive - Beaujon
RECRUITINGClichy, 92110, France
-
Service de Médecine Nucléaire, Groupe Hospitalier Bichat-Claude Bernard
ACTIVE_NOT_RECRUITINGParis, 75018, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a black seed extract boost immunotherapy against a rare cancer?
- Can a simple supplement soothe Radiation-Damaged rectums?
- Can imaging reveal how radiation shapes marrow recovery?
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- Can a video call replace a clinic visit for cancer patients on radiotherapy?